NCT03190174 2025-02-17Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain CancersSarcoma Oncology Research Center, LLCPhase 1/2 Completed34 enrolled 14 charts
NCT03623854 2024-04-16Nivolumab and Relatlimab in Treating Participants With Advanced ChordomaJonsson Comprehensive Cancer CenterPhase 2 Completed10 enrolled